{
    "ticker": "CYRX",
    "name": "CryoPort, Inc.",
    "description": "CryoPort, Inc. is a leading innovator in the temperature-controlled supply chain solutions industry, primarily serving the pharmaceutical and biotechnology sectors. Established in 2012, CryoPort specializes in the transportation of biological materials, including vaccines, cell therapies, and regenerative medicine products, ensuring that they are maintained at precise temperatures throughout the shipping process. The company\u2019s proprietary CryoPort Express\u00ae system combines state-of-the-art technology with a commitment to safety and compliance, enabling clients to meet stringent regulatory requirements. CryoPort's solutions are designed to enhance the efficiency and reliability of cold chain logistics, facilitating the successful delivery of temperature-sensitive healthcare products. The company has positioned itself as a strategic partner for companies engaged in advanced therapies, providing customized logistics solutions that cater to the unique challenges of the biopharma supply chain. CryoPort's mission is to support the advancement of life-saving therapies by ensuring that critical materials are transported safely and effectively. With a growing global footprint and a focus on innovation, CryoPort continues to expand its services to meet the evolving needs of its clients in the ever-changing landscape of healthcare.",
    "industry": [
        "Biotechnology",
        "Logistics"
    ],
    "headquarters": "Los Angeles, California, USA",
    "founded": "2012",
    "website": "https://www.cryoport.com",
    "ceo": "Jerrell Shelton",
    "social_media": {
        "twitter": "https://twitter.com/CryoPort",
        "linkedin": "https://www.linkedin.com/company/cryoport/"
    },
    "investor_relations": "https://investors.cryoport.com",
    "key_executives": [
        {
            "name": "Jerrell Shelton",
            "position": "CEO"
        },
        {
            "name": "Thomas S. Hodge",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Temperature-Controlled Logistics",
            "products": [
                "CryoPort Express\u00ae System",
                "CryoPort Express\u00ae Shippers"
            ]
        },
        {
            "category": "Supply Chain Solutions",
            "products": [
                "CryoPortal\u00ae Technology",
                "CryoStorage\u00ae Solutions"
            ]
        }
    ],
    "seo": {
        "meta_title": "CryoPort, Inc. | Innovative Temperature-Controlled Supply Chain Solutions",
        "meta_description": "Explore CryoPort, Inc., a leader in cold chain logistics for the biotech and pharmaceutical industries. Learn about their innovative solutions for transporting temperature-sensitive materials.",
        "keywords": [
            "CryoPort",
            "Cold Chain Logistics",
            "Temperature-Controlled Shipping",
            "Biopharma",
            "Cell Therapy Logistics"
        ]
    },
    "faq": [
        {
            "question": "What does CryoPort specialize in?",
            "answer": "CryoPort specializes in temperature-controlled supply chain solutions for the biotech and pharmaceutical industries."
        },
        {
            "question": "Who is the CEO of CryoPort?",
            "answer": "Jerrell Shelton is the CEO of CryoPort, Inc."
        },
        {
            "question": "Where is CryoPort headquartered?",
            "answer": "CryoPort is headquartered in Los Angeles, California, USA."
        },
        {
            "question": "What are CryoPort's main products?",
            "answer": "CryoPort's main products include the CryoPort Express\u00ae system and CryoPortal\u00ae technology."
        },
        {
            "question": "When was CryoPort founded?",
            "answer": "CryoPort was founded in 2012."
        }
    ],
    "competitors": [
        "PODD",
        "CFRX",
        "TGTX"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "BMY"
    ]
}